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Background: In onchocerciasis endemic areas in Africa, heterogenous biting rates by 23 
blackfly vectors on humans are assumed to partially explain age- and sex-dependent infection 24 
patterns with Onchocerca volvulus. To underpin these assumptions and further improve 25 
predictions made by onchocerciasis transmission models, demographic patterns in antibody 26 
responses to salivary antigens of Simulium damnosum s.l. are evaluated as a measure of 27 
blackfly exposure.  28 
Methodology/Principal Findings: Recently developed IgG and IgM anti-saliva 29 
immunoassays for S. damnosum s.l. were applied to blood samples collected from residents in 30 
four onchocerciasis endemic villages in Ghana. Demographic patterns in antibody levels 31 
according to village, sex and age were explored by fitting generalized linear models. 32 
Antibody levels varied between villages but showed consistent patterns with age and sex. 33 
Both IgG and IgM responses declined with increasing age. IgG responses were generally 34 
lower in males than in females and exhibited a steeper decline in adult males than in adult 35 
females. No sex-specific difference was observed in IgM responses. 36 
Conclusions/Significance: The decline in age-specific antibody patterns suggested 37 
development of immunotolerance or desensitization to blackfly saliva antigen in response to 38 
persistent exposure. The variation between sexes, and between adults and youngsters may 39 
reflect differences in behaviour influencing cumulative exposure. These measures of antibody 40 
acquisition and decay could be incorporated into onchocerciasis transmission models towards 41 
informing onchocerciasis control, elimination, and surveillance. 42 
Author summary 43 
Onchocerciasis, a disease caused by the helminth parasite Onchocerca volvulus, is transmitted 44 
by the bites of female Simulium blackflies. The disease is still endemic in many African 45 
countries, and the World Health Organization has proposed elimination of its transmission in 46 
 
 
12 countries by 2030. Understanding the heterogeneity in human exposure to vector bites can 47 
help discern which portion of the population is at higher risk of acquiring/ transmitting 48 
infection and is fundamental to identifying target groups for serological monitoring and 49 
transmission control. Traditionally, blackfly biting rates are estimated by performing human 50 
landing catches, a method that is often considered unethical and which can be unreliable as a 51 
representative measure. Therefore, we used our recently developed immunoassays to measure 52 
human antibody responses to antigens contained in the saliva of blackflies and deposited into 53 
human skin when they bloodfeed. In onchocerciasis endemic communities in Ghana, we 54 
measured antibody responses to understand age- and/or sex-related demographic patterns in 55 
vector exposure. We observed lower antibody responses in males compared to in females, and 56 
a substantial decline with increasing age, suggesting that high blackfly biting pressure induces 57 
desensitization in the human host.  58 
Introduction 59 
Female blackflies of the Simulium damnosum sensu lato (s.l.) complex are the predominant 60 
vectors of Onchocerca volvulus in Africa. This filarial nematode causes human 61 
onchocerciasis, commonly known as river blindness and proposed for elimination of 62 
transmission (EOT) in 12 countries by 2030 [1]. Repeat exposure to bites of infective 63 
blackflies is a key driver of parasite acquisition, and high biting rates are important 64 
determinants of transmission intensity and resurgence following control interventions, 65 
particularly those based on mass drug administration (MDA) of ivermectin [2,3]. Therefore, 66 
‘stop-MDA surveys’ and post-treatment surveillance protocols would be improved by 67 
monitoring exposure to vector bites in addition to exposure to the parasite and assessment of 68 
residual infection in informative age and sex groups depending on the epidemiological setting 69 
[4,5]. Annual biting rates (ABR, the number of bites/person/year) are predominantly 70 
estimated by performing human landing catches (HLCs) [6], but this is both labour-intensive 71 
 
 
and often considered unethical. Furthermore, HLC methods likely lead to biased estimates of 72 
ABRs as they are typically performed on a few adult males at the riverbank close to blackfly 73 
breeding sites, where biting rates are likely to be higher and vector collectors are maximally 74 
exposed [7]. Thus, HLCs may not capture the true exposure representative of the community, 75 
age or sex groups or their activity patterns. Furthermore, when blackfly densities are high, 76 
HLCs may be unable to capture all biting events thereby underestimating the biting rate [8,9]. 77 
Applying novel methods to measure individual and population exposure to blackfly vector 78 
bites would greatly inform our understanding of exposure patterns to onchocerciasis and 79 
inform mathematical transmission modelling of control and elimination [2]. 80 
Proteins in the saliva of blood-seeking arthropod vectors of human and veterinary diseases 81 
provoke an immunomodulatory response in vertebrates following their exposure to vector 82 
bites (e.g. by mosquitoes, sand flies, triatomine bugs, and tsetse flies) [10]. Measurement of 83 
host anti-saliva antibodies has proven a useful surrogate marker to monitor individual host 84 
biting rates [11–15], seasonal variations in exposure and infection [16,17], and to evaluate 85 
vector control interventions [18–22]. Immunoassays to measure human anti-saliva antibody 86 
responses to blackfly bites have not been available until recently developed by the authors, 87 
specifically to measure human IgG and IgM antibody responses to saliva of S. damnosum s.l. 88 
which is the main vector in Africa including the study sites in Ghana [23].  89 
In the present study we report on the demographic patterns revealed by applying these assays 90 
to community residents in the Bono East region of Ghana, a savannah setting. This area was 91 
under vector control during the Onchocerciasis Control Programme in West Africa (OCP, 92 
1974–2002) [24,25], and is where the first ivermectin community trials were conducted in the 93 
late 1980’s [26]. However, transmission persists despite many years of annual MDA, even 94 
after adopting biannual MDA in 2010 [27,28]. With the risk of residual transmission leading 95 
to possible resurgence of human infections if MDA were to stop [3], the area has been the 96 
 
 
subject of comprehensive entomological [27,29–31], parasitological [32] and parasite 97 
genomic [33] research, and a source of valuable epidemiological and entomological data for 98 
parameterizing onchocerciasis transmission models [34–36]. Due to the lack of reliable tools 99 
to independently measure human exposure to vector bites, mathematical models have 100 
assumed age- and sex-dependent exposure rates based on patterns of human infection with O. 101 
volvulus. However, modelling outputs used to inform EOT and surveillance strategies are 102 
sensitive to such patterns [4,37]. The aim of this study is to apply our novel human IgG and 103 
IgM immunoassays as indicators of individual biting exposure, both between and within (by 104 
age and sex) onchocerciasis-endemic communities. The generated demographic patterns will 105 
help to scrutinize mathematical modelling assumptions. 106 
Material and methods 107 
Ethical statement  108 
Ethical clearance was obtained from the Council for Scientific and Industrial Research (CSIR) 109 
Institutional Review Board (RPN008/CSIR-IRB/2019) in Accra, Ghana. Residents were 110 
informed of the objectives of the study and participants provided fully informed written 111 
consent; parents or guardians provided consent for <18-year-olds. At the time of the study, 112 
ivermectin treatment against onchocerciasis was administered as part of the on-going national 113 
biannual MDA programme [38]. Each participant was rewarded with a bar of washing soap, a 114 
commercial sachet of malt drink powder (Milo, Nestlé) and a can of condensed milk. Blackfly 115 
collections were carried out by local OCP vector collectors following standard HLC 116 
techniques [39]. Individual identifiers on data records were anonymized prior to analyses and 117 
data storage. 118 
Study area 119 
The study was conducted during the wet season in August 2019 in rural villages in an 120 
onchocerciasis-endemic area of the Pru river basin, Pru District, in the Bono East region of 121 
 
 
Ghana. Fig 1 provides a map of the study area and the location of the study communities, 122 
created using the ‘ggplot2’ and the ‘rworldmap’ package in R software [40,41]. 123 
 124 
Fig 1. Map of Ghana indicating study communities in the Pru District, Bono East region.  125 
 126 
Recruitment, blood sampling and demographic information 127 
Villages were selected on the criteria that (a) there was evidence of exposure to 128 
S. damnosum s.l. vector bites [30,42], (b) they were under current ivermectin treatment as part 129 
of the national onchocerciasis control programme [43], (c) the villages comprised >200 130 
residents, and (d) the villages represented variable ABRs based on previous records [30,42]. 131 
Five villages were selected; due to the proximity of two of the villages, these were grouped 132 
into a single cluster (Asubende and Senyase (ASU/SEN) resulting in four village clusters. 133 
These included ASU/SEN, with high biting rates (400‒850 flies/person/month), Beposo 134 
[BEP] with moderate values (100–350), and Fawoman [FAW] and Ohiampe [OHI] with 135 
lower biting rates (25–175 flies/person/month) [30,42].  136 
To obtain blood samples from the village residents, two recruitment approaches were 137 
adopted: in villages with <300 residents (ASU/SEN, FAW, and OHI) all residents were 138 
invited to participate. In the larger village (BEP) an age/sex stratified sample was identified 139 
based on assigning random numbers generated using R software [44], to the pages of the 140 
paper-based census records compiled by the MDA programme. The households contained on 141 
randomly selected pages were noted and invited to participate until reaching an estimated 142 
sample of houses containing 250 individuals as required from statistical calculations (i.e. 143 
~1000 individuals in total across the four village clusters). Children younger than 4 years old 144 
were not recruited.  145 
 
 
A total of 958 participants were finally recruited, all tested for IgG antibodies, and a subset of 146 
500 individuals tested for IgM antibodies (Table 1). For age stratification purposes, the 147 
identified populations in all villages were divided into eight age categories (in years): 5–10, 148 
11–20, 21–30, 31–40, 41–50, 51–60, 61–70,  71, aiming to recruit 32 residents per age class 149 
in each village, split equally between the sexes. In the case of IgM, samples were selected by 150 
random number generation assigned to the ordered age-stratified full list of samples and 151 
aimed to test around 40-60% of the samples tested by IgG per age class, with some variability 152 
in percentage tested in the oldest age group. The numbers tested per age and sex strata per 153 
village cluster are shown in Figs A and B and Table C in S1 File. The geographical 154 
coordinates, elevation and number of individuals sampled and tested for each 155 
immunoglobulin per village cluster are shown in Table 1. 156 
Table 1. Study communities, their geographical coordinates, elevation and numbers of 157 
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Participants in each village/cluster were invited to the local school and assigned a 161 
subject/sample identification number written on a personalized card. Two to four ml of blood 162 
were collected into Ethylene Diamine Tetra Acetic acid (EDTA) tubes by venipuncture and 163 
kept cool for 2–3 hours in an insulated cool box until centrifugation at 2500 rpm for 15 min to 164 
separate the plasma. Samples were stored at 7 C until ELISA testing. Metadata on name, age, 165 
sex, number of years of residence, house number, name of household head, and history of 166 
clinical onchocerciasis were collected.  167 
Immunoassays to measure human exposure to blackfly bites 168 
Enzyme-linked immunosorbent assays (ELISA) previously developed were performed to 169 
measure anti-S. damnosum s.l. saliva IgG and IgM human responses [23]. Briefly, host-170 
seeking S. damnosum s.l. females were collected following standard OCP vector collector 171 
techniques in one study location (ASU), near the Pru river [39]. All collected flies were stored 172 
in a cool box until dissected on the same day. The collected flies were anesthetized in a –20 173 
C freezer for 10 min after which their salivary glands were removed, and aliquots stored in 174 
Tris-buffered saline (TBS) (one gland per µl TBS, pH 7.5) at –20 C until further use. Flat-175 
bottom 96-well microtiter plates (ThermoFisher Scientific) were coated with blackfly salivary 176 
gland homogenate (SGH) with 0.2 g SGH/well (for IgG ELISA) or 0.025 g SGH/well (for 177 
IgM ELISA) and incubated overnight at 4 C. The plates were blocked with 6% non-fat dried 178 
milk (Bio-Rad) in phosphate-buffered saline (PBS) with 0.05% Tween 20 (PBS-Tw) and 179 
incubated with sera diluted 1/100 (IgG ELISA) or 1/50 (IgM ELISA) in 2% non-fat dried 180 
milk. The plates were washed and incubated with peroxidase-conjugated anti-human IgG 181 
(1/1,000) or IgM antibody (1/70,000) (Sigma-Aldrich; Bethyl Laboratories, Inc). The ELISA 182 
was developed using an orthophenylendiamine (OPD) solution in a phosphate-citrate buffer 183 
(pH 5.5) with 0.1% hydrogen peroxide. The reaction was stopped after 5 min with 10% 184 
sulfuric acid and the absorbance, optical density (OD) value was measured at 492 nm using a 185 
 
 
Tecan Infinite M200 microplate reader (Schoeller). Further details of blackfly collection, 186 
dissection, and the immunoassays were previously reported [23]. 187 
Data standardization 188 
All plasma samples were tested in duplicate. Samples with a coefficient of variation (CoV) of 189 
more than 20% were retested. Each plate included a blank control, the OD value of which was 190 
subtracted from the sample OD values. A set of two positive (PC) and two negative control 191 
(NC) samples were included in each plate to correct for inter-plate variability according to the 192 
following formula: Standardized Optical Density (SOD) = ODsample/(average ODPC – average 193 
ODNC). Furthermore, a PC sample was titrated in duplicate on three separate plates at seven 194 
serial dilutions from 1/50 to 1/3,200. The average of the three log-logit transformed standard 195 
curves was used to convert and standardize sample SOD values which are reported below as 196 
anti-saliva antibody arbitrary units/ml.  197 
Sample size calculation 198 
Sample sizes were calculated to achieve 90% statistical power (with type I error, =0.05) to 199 
detect a difference in mean IgG SOD antibody levels between males and females, for an 200 
unpaired two-sample effect size DCohen of 0.23 and a variance in SOD of 0.16 [45].  By adding 201 
15% to the calculated sample size as a correction factor for subsequent non-parametric 202 
statistical testing, 460 people per sex group were required [46]. This estimate is also based on 203 
the reasonable assumption that the differences in the mean antibody responses of the sexes 204 
between clusters would be minimal as confirmed by subsequent analyses (test of village 205 
cluster  sex interaction term: P>0.243). The equivalent statistical power to detect a 206 
difference in IgM responses between sexes with an effect size DCohen of 0.3 and a variance in 207 




Statistical analyses 210 
Differences between clusters or sex categories were statistically tested by Wilcoxon rank sum 211 
or Kruskal-Wallis tests with post-hoc Holm adjustment for multiple comparisons. Changes in 212 
immune responses with age and/or sex were tested by fitting generalized linear models 213 
(GLM) to the IgG and IgM anti-blackfly saliva antibody values, where a gamma distribution 214 
and log-link function gave the best fit by log-likelihood goodness-of-fit statistics. Age, sex 215 
and cluster interaction terms were tested, treating age as a continuous variable. Residence 216 
duration (years) and age showed high multicollinearity; hence only age was retained in the 217 
models. Correlation coefficients (rs) between median IgG and IgM responses by age and sex 218 
were estimated by the Spearman’s rank method. All statistical analyses were performed in R 219 
software [44], and graphical representations created using the ‘ggplot2’ package in R [40].  220 
Results 221 
Univariate analyses of population antibody response distributions  222 
A total of 958 participants (186–263 per village cluster) between the ages of  5 to  96 years 223 
old were recruited and sampled for anti-saliva IgG antibodies; demographic characteristics are 224 
summarized in Table 2 and in Figs A and B in S1 File. No differences were observed in the 225 
age compositions between village clusters or between sexes, nor in the frequencies of 226 
participants per age group (Figs A and B in S1 File). Thus, it is unlikely that the variations in 227 
age-sex compositions of village clusters were a source of statistical bias. 228 
Univariate analyses of demographic variables detected significant differences between the 229 
median IgG responses among village clusters (P<0.001) (Fig 2A), and the median IgG 230 
responses of males and females (P<0.05) (Fig 2B). Equivalent differences were not observed 231 
in IgM responses (Fig 3); however, both IgG and IgM median antibody responses declined 232 
with age (P<0.001) (Fig 2D and 3D). A breakdown of the IgG and IgM antibody distribution 233 




Fig 2. Human anti-blackfly saliva IgG antibody responses according to cluster, sex, and 236 
age. Boxplots showing the distributions of IgG responses (A) by cluster, (B) by sex, (C) by 237 
age, and scatterplot (D) by age and sex (points) showing the best-fit lines (solid lines). IgG 238 
levels are shown as units/ml. F: female; M: male. Village clusters: ASU/SEN: Asubende/ 239 
Senyase; BEP: Beposo; FAW: Fawoman; OHI: Ohiampe.  240 
 241 
Fig 3. Human anti-blackfly saliva IgM antibody responses according to cluster, sex and 242 
age. Boxplots showing the distributions of IgM responses (A) by cluster, (B) by sex, (C) by 243 
age, and scatterplot (D) by age and sex (points) showing the best-fit lines (solid lines). IgM 244 
levels are shown as units/ml. F: female; M: male. Village clusters: ASU/SEN: Asubende/ 245 




Table 2. Summary statistics of participants and median antibody titres by immunoglobulin and village/cluster. 248 
 249 
The interquartile range (Q1 and Q3) of age, duration of residency, and the antibody titres are shown in brackets. Reported biting rates are 250 
according to [30,42]. All: All clusters together; village clusters: ASU/SEN: Asubende/Senyase; BEP: Beposo; FAW: Fawoman; OHI: Ohiampe. 251 









Median duration of residency  
(Q1 – Q3)  
(in years) 





All 958 21.0 (11.0 – 42.0) 0.84:1 (437:521) 16.0 (8.0 – 32.0) 2478.13 (1550.05 – 3413.36) NA 
ASU/SEN 186 24.0 (14.0 – 39.0) 1:1 (93:93) 20.0 (10.0 – 35.0) 2507.34 (1699.94 - 3125.95) High 
BEP 253 25.0 (11.0 – 46.0) 0.83:1 (115:138) 24.5 (11.0 – 46.0) 1951.63 (1269.37 – 2822.26) Moderate 
FAW 263 22.0 (10.0 – 40.0) 0.71:1 (109:154) 13.0 (6.0 – 26.0) 2590.61 (1662.54 – 3535.01) Low 
OHI 256 17.0 (11.0 – 40.5) 0.88:1 (120:136) 14.0 (7.0 – 24.0) 2956.20 (1703.47 – 4430.85) Low 
IgM 
All 500 21.5 (10.0 – 42.0) 0.85:1 (230:270) 17.0 (7.0 – 35.0) 3628.43 (1687.59 – 9923.29) NA 
ASU/SEN 97 23.0 (12.25 – 36.75) 1.37:1 (56:41) 21.0 (9.25 – 35.75) 2956.66 (1496.31 –  7690.82) High 
BEP 137 24.0 (10.0 – 45.0) 0.72:1 (58:81) 24.0 (10.0 – 45.0) 4021.58 (1462.01 – 10396.13) Moderate 
FAW 124 23.0 (9.0 – 40.0) 0.77:1 (54:70) 11.0 (6.0 – 29.0) 4102.16 (2148.38 – 10473.40) Low 
OHI 140 17.5 (9.0 – 42.0) 0.79:1 (62:78) 15.0 (7.0 – 25.0) 3569.30 (1561.18 – 10754.69) Low 
 
 
Multivariate analyses of IgG responses according to village cluster, sex and age  253 
Accounting for cluster ID, sex, age, and the age x sex interaction term, multivariate models 254 
revealed that IgG responses were significantly lower in BEP than in ASU/SEN (P<0.01), 255 
similar between ASU/SEN and FAW (P=0.406), and higher in OHI than in ASU/SEN 256 
(P<0.001) (Figs 4A and 5). Generally, males exhibited lower IgG responses than females 257 
(P<0.001) (Figs 4B and 5). Fig 5 illustrates the (exponentiated) regression coefficient 258 
estimates of the final model (summarized in Table F in S1 File).  259 
 260 
Fig 4. Regression effect plots for all explanatory variables contained in the final model 261 
for the IgG responses. Each plot visualizes the effect of a specific explanatory variable while 262 
fixing the others to their reference level. The panels show the variations in responses between 263 
village clusters (A), sex (B), age (C), and an interaction between age and sex (D). The vertical 264 
lines in panel A and B and the shaded regions around the lines in panel C and D represent the 265 
95% confidence intervals. M = Male; F = Female. Village clusters: ASU/SEN: 266 
Asubende/Senyase; BEP: Beposo; FAW: Fawoman; OHI: Ohiampe. 267 
 268 
Fig 5. Exponentiated regression coefficient estimates for the final model per assay. The 269 
regression coefficient estimates for the final model are shown for IgG responses (A), and IgM 270 
responses (B). The circles represent the exponentiated mean coefficient estimate, the value 271 
shown above the corresponding circle, and the horizontal lines represent the 95% confidence 272 
intervals of the estimate. Significance levels *** P<0.001; ** P<0.01; * P<0.05. The 273 
referents were Asubende/Senyase for village clusters, and females for both sex and the age   274 




IgG anti-saliva antibody responses decreased with increasing age in both sexes (P<0.001) 277 
(Figs 4C and 5), but the response in males declined at a faster rate than in females (test of age 278 
 sex interaction term; P<0.001) (Figs 4D and 5). Both adult male and female participants 279 
≥18 years old exhibited lower IgG antibody levels than those aged <18 years 280 
(Pfemales<0.001; Pmales<0.001) (Fig 5). Males and females in pre-teenage years showed a 281 
similar antibody decline with increasing age (age  sex interaction: P = 0.328), whereas in 282 
adults the decline was more rapid in males than in females (age  sex interaction: P<0.01) 283 
(Fig 4D). 284 
 285 
Multivariate analyses of IgM responses according to village cluster, sex or age 286 
Equivalent multivariate analyses of anti-saliva IgM antibody responses for 500 recruits (Table 287 
1) indicated no significant variation between study clusters (PBEP = 0.403; PFAW = 0.301; POHI 288 
= 0.632) or sex (P = 0.405) (Figs 5 and 6A-B). However, there was a general decline in 289 
response magnitude with increasing age (P<0.01) (Figs 5 and 6C), but in contrast to IgG, the 290 
decline with age was not significantly different between sexes (test of age  sex interaction 291 
term: P=0.726) (Fig 6D). Fig 5 illustrates the (exponentiated) regression coefficient estimates 292 
of the final model (summarized in Table F in S1 File). 293 
 294 
Fig 6. Regression effect plots for all explanatory variables contained in the final model 295 
for the IgM responses. Each plot visualizes the effect of a specific explanatory variable 296 
while fixing the others. The panels show the variations in responses between village clusters 297 
(A), sex (B), age (C), and an interaction between age and sex (D). The vertical lines in panel 298 
A and B and the shaded regions around the lines in panel C and D represent the 95% 299 
confidence intervals. M = Male; F = Female. Village clusters: ASU/SEN: Asubende/Senyase; 300 




Correlation between IgG and IgM responses 303 
The correlation between IgG and IgM antibody responses was generally low (rs = 0.10, 304 
P<0.05), and not dissimilar considering females or males alone (females: rs = 0.12, P<0.1; 305 
males: rs = 0.08, P=0.21) (Fig F in S1 File). 306 
 307 
Discussion 308 
This study measured human antibody responses against blackfly saliva as an indicator of 309 
individual bite exposure; an approach that has been validated for several vector–host systems 310 
with the exception of blackflies [47,48]. Simuliids are important disease vectors of human and 311 
bovine onchocerciasis [49], mansonelliasis caused by Mansonella ozzardi [50], and vesicular 312 
stomatitis virus [51], yet they have not received as much attention as sand fly, mosquito or 313 
tick vectors. Only recently, we successfully developed novel immunoassays against blackfly 314 
saliva and this is the first study to apply these tools to an epidemiological setting.  The 315 
appropriate use of these assays will also improve our understanding of O. volvulus 316 
transmission dynamics and will be used to monitor changes in biting rates and the success of 317 
vector control interventions [23]. Heterogenous exposure to blackfly bites is an important 318 
determinant of the observed age- and sex-dependent profiles of O. volvulus infection [5]. 319 
Evaluating age- and sex-associated exposure patterns using empirically collected data can 320 
help inform transmission dynamics models, as these currently use assumed age- and sex-321 
dependent exposure patterns that have, at best, been derived from fitting the models to age- 322 
and sex-specific infection profiles [5].  Such assumptions influence the choice of informative 323 
age groups for serological monitoring in stop-MDA surveys [4], and have implications for 324 
understanding the contribution of currently untreated groups to transmission and morbidity 325 
[37], as well as for the design and evaluation of potential prophylactic strategies [52]. Testing 326 
 
 
such assumptions with independently collected data is crucial for better parameterization of 327 
transmission models and improved design of epidemiological surveys and surveillance 328 
strategies. Therefore, we explored age-and sex-related patterns of IgG and IgM antibody titres 329 
against S. damnosum s.l. saliva across well characterized endemic communities.  330 
Both IgG and IgM antibody levels were high in children and gradually declined with 331 
increasing age. Similar trends have been observed in human antibody responses to the saliva 332 
of several mosquito species [53–58], posing the question of whether these patterns indicate 333 
decreasing exposure to vector bites with age, or increasing immune tolerance and 334 
desensitization with persistent or cumulative saliva exposure [59–62]. Investigation of human 335 
IgG responses to sand fly saliva supports the latter proposition, with higher anti-saliva 336 
antibody responses observed in new compared to long-term residents of a sand fly-endemic 337 
region [63]. Similarly, desensitization to salivary antigens was detected in an area colonized 338 
for more than 25 years by Aedes mosquitoes, compared to an area where individuals had been 339 
exposed for no longer than 5 years [54]. Following that pattern, median IgG antibody 340 
responses also tended to be lower in the current study villages where higher S. damnosum s.l. 341 
biting rates were previously reported [30,42]. Antibody responses to Anopheles mosquito 342 
bites measured after the summer season of high vector abundance were considerably higher 343 
than those before the summer season; notwithstanding they consistently declined with 344 
increasing host age [54,55]. Interestingly, in that study the decline appeared to be antigen-345 
dependent, as the trend was not detected in antibody responses to a specific recombinantly-346 
expressed protein as opposed to the whole salivary gland homogenate [64–66]. Several 347 
immunogenic proteins were recently detected in S. damnosum s.l. saliva of which most were 348 
well-known salivary antigens [23]. Future expression of these in recombinant forms may be 349 
instructive and increase assay sensitivity. This is especially interesting for IgM as these 350 
antibody responses were shown to be less specific than the IgG responses [23]. 351 
 
 
The median IgG response was lower in males than females, which can be attributed to the 352 
greater rate of decline of the IgG response with increasing age in males. This may reflect sex 353 
differences in behaviour such as daily habits, occupation, education, or clothing, that 354 
influence physical exposure to blood-seeking blackflies. Male occupants of most ages are 355 
responsible for agriculture, farming and fishing in the Pru region and may be less well 356 
covered by protective clothing, whereas women are more covered, spend more time at home 357 
performing domestic duties and/or engage in long-distance trading activities [67,68]. The 358 
current study was limited in not recording the daily activities of the participants, though biting 359 
blackflies appeared to be ubiquitous throughout the day within villages. That females show 360 
greater levels of non-specific innate and adaptive immune responsiveness than males, 361 
particularly post-puberty, suggests that hormonal involvement (reviewed in [69]) may 362 
contribute to the sex differences observed in this study.  363 
A non-mutually exclusive alternative driving factor behind the observed decline in antibody 364 
levels may also be a lower exposure to blackfly bites with increasing age. Such patterns of 365 
exposure were predicted by fitting age- and sex-structured onchocerciasis transmission 366 
mathematical models to age- and sex-specific profiles of O. volvulus skin microfilariae in 367 
another African savannah setting [5]. However, the model fits also indicated that vector 368 
exposure of females should increase (rather than decrease) with age. If this is correct, and if 369 
women indeed are more intensely exposed as they age, it further supports the case for 370 
desensitization with increased long-term biting exposure. Therefore, one next step to better 371 
understand exposure patterns with age and sex is to fit dynamic models of antibody 372 
acquisition and decay to the (IgG) data obtained here [70,71]. Future studies of the molecular 373 
and cellular mechanisms that underly immune tolerance and progressive desensitization to 374 
blackfly saliva would also be most informative. Variations in IgG subclass responsiveness are 375 
 
 
also possible as shown against Anopheles or Aedes saliva [55,72]. Interestingly, human IgG4 376 
amongst bee-keepers was found to be associated with immunotolerance to bee venom [73,74]. 377 
Less clear in this study were the age and sex-related trends in IgM responses. 378 
Although they also declined with age supporting the immunological desensitization 379 
hypothesis, IgM responses are generally shorter lived than IgG responses, hence, likely to be 380 
more indicative of recent exposure. A shorter half-life together with a lack of cumulative 381 
increase after repeat exposure may partially explain the large number of low IgM responses 382 
observed in the village residents, and the lack of correlations between individual host IgG and 383 
IgM responses, particularly as the current study was limited to cross-sectional sampling 384 
during the high biting season.  385 
Future studies would benefit from quantifying short- and long-term kinetics in 386 
individual anti-saliva Ig responses in the context of seasonal fluctuations in vector abundance 387 
and distance to vector breeding habitats, to refine our understanding of the link between biting 388 
rates and the Ig responses [16,53,54]. In fact, it would be very informative if antibody data 389 
generated using our immunoassays could be used in spatial analyses to better understand 390 
patterns of vector–human contact with increasing distance from breeding sites. At present, 391 
mapping exercises such as those used for Onchocerciasis Elimination Mapping (OEM) collect 392 
information on the distribution of breeding sites and vector presence. Our novel tool could 393 
complement OEM to identify high-risk locations where exposure to vector bites would 394 
provide additional information to seroprevalence surveys to guide start-MDA decisions and 395 
identify informative age/sex groups for sampling [75]. Most of the information about the 396 
relationship between vector density and distance from breeding sites pertains to African 397 
savannah settings (such as those explored here), with less data available to characterize such a 398 
relationship in forest and forest-savannah mosaic settings. Therefore, if our anti-vector saliva 399 
assays could be combined with (seroprevalence) parasite exposure assays for a range of 400 
 
 
epidemiological settings, it would be possible to obtain valuable information to help 401 
elimination efforts. However, this necessitates the testing and validation of our assays for 402 
other species/cytoforms of the S. damnosum complex.  403 
The predominant vector species in the Bono East region are the savannah members of 404 
the complex, S. damnosum sensu stricto/S. sirbanum [27,30]. It remains to be established if 405 
the anti-S. damnosum s.l. IgG and IgM antibody responses represent a damnosum complex-406 
specific marker, or if member-specific markers of exposure would be more sensitive. We 407 
acknowledge that more data need to be collected to ascertain the validity of our 408 
immunoassays to reliably measure exposure to vector bites. Regarding empirical approaches, 409 
there are no experimental or observational data yet to precisely quantify the relationship 410 
between anti-salivary antibody levels and the number of vector bites. As colonizing blackflies 411 
in the laboratory is notoriously difficult, collecting field data to understand the kinetics of the 412 
antibody responses over a specified time frame would be helpful, particularly in settings with 413 
strong seasonality, in which vector biting ceases or greatly decreases for several months 414 
during the year. Regarding theoretical approaches, and as mentioned earlier, the exposure 415 
profiles predicted by age- and sex-structured onchocerciasis transmission models are broadly 416 
consistent with the proposed desensitization hypothesis. If this proves to be the case, we 417 
expect vector saliva-naïve children still to respond well to salivary antigens as an indication of 418 
continued exposure to vector bites pre- or post-MDA campaigns in areas with no vector 419 
control or without major ecological changes affecting vector density. Our assay could then be 420 
used to understand potential secular trends in vector biting rates due to anthropogenic change. 421 
Ideally, multiplex assays could be developed to test simultaneously for both exposure to 422 




Serological anti-saliva assays are useful tools to complement information collected by HLCs 425 
by measuring human-vector contact and revealing heterogeneities in exposure at the 426 
individual and community level that cannot be unravelled by HLCs alone. By novel 427 
application to four onchocerciasis-endemic communities, this study successfully evaluated 428 
age- and sex-related demographic patterns in blackfly bite exposure. The analyses uncovered 429 
the possibility of age- and sex-specific immunotolerance or desensitization to blackfly saliva, 430 
likely resulting from cumulative blackfly exposure with age. Concomitant studies of infection 431 
levels in humans and flies, vector abundance, and immune responses to blackfly saliva and 432 
parasite antigens would greatly help to better understand transmission risk and intensity, and 433 
improve parameterization of transmission models with which to inform optimal interventions 434 
and surveillance strategies to achieve and protect onchocerciasis elimination. 435 
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